12:00 AM
 | 
Aug 18, 2008
 |  BC Week In Review  |  Company News  |  Other News

Enzon drug delivery, infectious, cancer news

Enzon will explore strategic alternatives for its specialty pharmaceutical business while the company continues to pursue a plan to spin out its biotech business. Alternatives the company is considering include selling the entire specialty pharma business and selling its Indianapolis, Ind., manufacturing facility...

Read the full 195 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >